14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $189.44 $217.57 Thursday, 25th Apr 2024 BIIB stock ended at $202.46. This is 0.233% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.66% from a day low at $198.11 to a day high of $205.36.
90 days $189.44 $251.99
52 weeks $189.44 $319.76

Historical Biogen Inc. prices

Date Open High Low Close Volume
Apr 25, 2024 $201.21 $205.36 $198.11 $202.46 1 589 471
Apr 24, 2024 $198.97 $205.75 $198.97 $201.99 3 241 586
Apr 23, 2024 $193.34 $195.86 $192.75 $193.18 1 437 456
Apr 22, 2024 $196.19 $196.67 $193.23 $194.11 1 113 423
Apr 19, 2024 $190.72 $194.53 $189.44 $194.38 1 599 173
Apr 18, 2024 $191.75 $192.55 $189.52 $190.52 1 481 410
Apr 17, 2024 $195.37 $195.55 $192.01 $192.16 1 320 234
Apr 16, 2024 $196.20 $197.73 $194.94 $195.15 871 591
Apr 15, 2024 $198.73 $199.53 $196.45 $196.80 1 153 671
Apr 12, 2024 $204.23 $205.24 $197.79 $198.18 1 223 199
Apr 11, 2024 $202.76 $204.74 $200.97 $203.68 1 017 431
Apr 10, 2024 $203.00 $203.99 $200.65 $201.55 872 232
Apr 09, 2024 $205.02 $209.06 $205.02 $206.52 961 313
Apr 08, 2024 $203.89 $205.77 $202.91 $204.95 723 651
Apr 05, 2024 $204.28 $205.19 $202.18 $203.87 922 972
Apr 04, 2024 $207.24 $210.00 $205.22 $205.30 758 607
Apr 03, 2024 $207.71 $208.70 $205.36 $206.38 870 310
Apr 02, 2024 $213.09 $213.37 $207.58 $207.64 1 461 772
Apr 01, 2024 $215.69 $215.69 $212.56 $214.83 823 955
Mar 28, 2024 $217.36 $217.57 $214.00 $215.63 1 760 515
Mar 27, 2024 $213.75 $216.34 $212.95 $216.34 1 241 426
Mar 26, 2024 $216.15 $216.67 $211.02 $212.02 1 589 049
Mar 25, 2024 $217.77 $218.26 $215.59 $216.69 679 177
Mar 22, 2024 $221.30 $221.30 $215.36 $218.10 1 046 831
Mar 21, 2024 $219.33 $221.74 $217.95 $220.75 994 897
Click to get the best stock tips daily for free!

About Biogen Inc.

Biogen. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an ad... BIIB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT